Like what you read? Get new posts delivered straight to your inbox!
Contact Us | Follow Us
Experience. Integrity. IMPACT.
What We Do

Holly Buchanan, M.S., RAC, Promoted to Principal Consultant

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In March 2020, Holly Buchanan, M.S., RAC, was promoted to the position of Principal Consultant at Impact Pharmaceutical Services, Inc. (IMPACT).

Holly joined IMPACT in 2017 with over 15 years of medical writing, regulatory, and program management experience within CRO and pharmaceutical environments. Holly’s experience ranges from early to late phase drug development, with her most recent experiences being on original marketing applications, as well as line extensions and responses to regulatory agency questions. Holly is an excellent reviewer who embraces our commitment to a culture of learning, serving as a mentor to many of our more junior medical writers and fostering their career development.

Holly’s expertise as a submission project manager is especially notable. From small biotech to large pharmaceutical clients, Holly does an outstanding job of recognizing the unique aspects of each submission and developing a plan, timeline, and associated documents to accomplish each client’s goal. Holly’s commitment and professionalism to her projects results in the development and maintenance of strong client relationships that help strengthen IMPACT’s reputation in the industry.

“Holly’s promotion to Principal Consultant is very well deserved and is reflective of the fact that she is an extremely talented medical writer and drug development professional, as well as a stellar project manager,” said Chrissy Williams, IMPACT Associate Director of Medical Writing and Submission Management. “Holly is also an excellent mentor who is noted for her willingness to take the time to teach and explain whilst helping to keep things in perspective with her patience and sense of humor! She truly is a trusted resource for her colleagues and client teams alike. We are lucky to have Holly as an integral member of the IMPACT family!”

Tim Garver, Executive Vice President and COO at IMPACT, comments, “Holly is a consummate mentor, and this is clearly evident when considering how many people she’s influenced throughout her career at IMPACT. Her experience as a project manager and her depth of knowledge of submission documents make her an extremely valuable team member. Holly’s enthusiasm for the work and her investment in the growth and development of the company and our team are truly inspiring.”

IMPACT is a Contract Research Organization (CRO) located in Research Triangle Park, NC. Our team consists of drug development professionals who specialize in medical writing and quality control, drug development consulting, regulatory affairs, regulatory operations, and program management.

Media Contact:

Mark A. Cierpial, PhD, Chief Executive Officer
Phone: (919) 899-9248
Fax: (919) 354-6090
mcierpial@impactpharma.com
www.impactpharma.com

6

Leave a Reply

Your email address will not be published. Required fields are marked *